Ribomic Inc. provided non-consolidated earnings guidance for the year ending March 31, 2024. For the year, the company expects loss of JPY 1,250 million or JPY 35.05 per share. Operating loss of JPY 1,366 million.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
84 JPY | 0.00% | +1.20% | -22.22% |
1st Jan change | Capi. | |
---|---|---|
-22.22% | 19.84M | |
+10.44% | 107B | |
+0.82% | 106B | |
+6.72% | 23.47B | |
-13.89% | 21.9B | |
-6.64% | 18.77B | |
-37.26% | 17.85B | |
-10.98% | 16.78B | |
+8.67% | 14.41B | |
+41.08% | 12.86B |
- Stock Market
- Equities
- 4591 Stock
- News Ribomic Inc.
- Ribomic Inc. Provides Non-Consolidated Earnings Guidance for the Year Ending March 31, 2024